Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

Inizio

- PMLiVE

Sandoz launches first and only multiple sclerosis biosimilar in US

The treatment is FDA-approved to treat MS and Crohn’s disease

- PMLiVE

Tonix launches new oral fibromyalgia treatment

Tonmya is the first approved treatment for adults with fibromyalgia in over 15 years

R:SQD logo

Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

Cuttsy + Cuttsy

- PMLiVE

Agility in medical affairs: responding to rapid market and regulatory shifts

By Maurice Leonard

- PMLiVE

Optimised therapy to improve outcomes for heart attack and stroke patients

Personalising therapy promises to revolutionise the treatment of thrombosis

- PMLiVE

The new era of medical affairs: busting myths and supercharging strategic value

‘MA creates the scientific conditions for long-term, trustworthy commercial success’

- PMLiVE

Does real-world use of AI in systematic literature reviews result in time and cost savings?

By Manca Povsic and Emma Griffiths

Amiculum

- PMLiVE

J&J’s Tremfya improves symptoms of psoriatic arthritis including joint damage

Psoriatic arthritis can develop in up to 30% of people with psoriasis

- PMLiVE

Novartis announces plans for new US manufacturing hub

The US hub is expected to create 700 new jobs by 2030

- PMLiVE

The most overlooked KPI in business? Joy

By Neha Desai Sulliman

- PMLiVE

Reimagining pharma CX: three game-changing products driving human-centric innovation

By Rachael McLoughlin

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links